North Carolina Medicaid Covers Wegovy and Zepbound. The State Health Plan Does Not.

Yes, North Carolina Medicaid covers Wegovy and Zepbound for obesity as of November 2026, with prior approval, a BMI of at least 30 (27 if a related condition is present) and ongoing nutrition and physical activity changes, terms close to Mississippi Medicaid’s weight-loss criteria.^[1][3] The State Health Plan for teachers and state employees does the opposite: it ended weight-loss coverage on April 1, 2024, and its October 2026 formulary lists neither drug.^[9][11]

Does North Carolina Medicaid cover Wegovy and Zepbound for weight loss?

Yes, and in both Medicaid Direct and managed care.^[2] The drug list effective October 1, 2026 groups the drugs as follows, and it bars the health plans from adding their own utilization rules on top.^[1]

That list has moved more than once in a year. The December 2025 reinstatement made Wegovy the only preferred product and asked patients to try it before Zepbound.^[2] Zepbound’s pen was still non-preferred on the April 2026 list and is preferred on the October one, so older guidance on trying Wegovy first no longer describes Zepbound’s pen.^[1]

What are the prior approval requirements?

The December bulletin returned Medicaid to the criteria dated August 1, 2024, and NC Medicaid’s pharmacy benefit administrator still posts that document as the current criteria.^[2][3] Its main terms are these.

A non-preferred product needs a documented reason or a trial of a preferred one, which the criteria define as 3 to 6 months to finish titration.^[3] The criteria were written before Foundayo and the Wegovy tablet, but the drug list says clinical criteria apply to every drug in the class.^[1] Our prior authorization guide explains how to prepare a request of this kind.

Are heart disease and sleep apnea covered by NC Medicaid?

Yes, and these uses stayed covered even during the 2025 cutoff.^[4][6] In November 2025 the state withdrew its separate criteria for them and said it would cover them according to each drug’s FDA-approved uses until revised criteria are adopted.^[6] The December reinstatement kept that approach.^[2] The current criteria posted by NC Medicaid’s pharmacy benefit administrator cover weight management only.^[3]

• Wegovy for cardiovascular risk: the label covers adults who already have heart disease and carry excess weight, to cut the chance of a heart attack, stroke or cardiovascular death.^[2] The weight-management criteria also accept a BMI of 27 from age 45 when cardiovascular disease is established (by contrast, Iowa Medicaid’s heart route starts at 18).^[3]
• Wegovy for MASH: the label covers adults whose fatty liver disease has caused fibrosis at stage F2 or F3 but not cirrhosis.^[17]
• Zepbound for sleep apnea: the label covers adults with obesity whose sleep apnea is moderate or severe.^[2] Our article on Medicaid and Zepbound covers the wider picture.

Diabetes GLP-1s sit in a separate class on the drug list with their own clinical criteria. Mounjaro, Ozempic pens, Trulicity, Victoza and Byetta are preferred there.^[1]

Why did NC Medicaid end and then restore coverage?

Funding, both times. In September 2025 the state announced the end of obesity coverage on October 1, citing shortfalls in state funding and calling the benefit optional; South Carolina Medicaid ended its own on December 31, 2025.^[4] On December 10, Governor Stein directed the health department to restore Medicaid rates to their September 30 levels, saying court orders required it and that a $319 million funding gap remained.^[5] Obesity coverage came back effective December 12 under that directive, 72 days after it ended.^[2] The department also told prescribers to consider whether patients needed a lower dose after a lapse.^[2]

Could NC Medicaid coverage change again?

Yes. Session Law 2026-1, approved April 30, 2026, told the Division of Health Benefits to write a savings plan that includes giving managed care plans room to control weight-loss GLP-1 use, including mandatory nutrition, weight-loss and lifestyle programs.^[7] The plan was due to lawmakers by October 1, 2026, it may not take effect before July 1, 2027, and it may not touch coverage for diabetes, heart disease or other non-weight-loss uses.^[7] We found no published copy of that report as of November 6, 2026.

The price tag explains the attention. Carolina Journal, citing state health department figures, reported that 34,524 beneficiaries had weight-loss GLP-1 claims in June 2026. Those claims came to $47,855,225, a figure that precedes federal matching funds and undisclosed manufacturer rebates.^[8] That is news reporting of state data; we could not find the underlying figures in a state document. North Carolina could also join the federal BALANCE model through January 1, 2027, though CMS names no participants on its page.^[18] Our BALANCE explainer covers what joining would mean.

Does the North Carolina State Health Plan cover Wegovy or Zepbound?

Not for weight loss. The plan’s formulary effective October 1, 2026 has no entry for Wegovy, Zepbound, Saxenda or Foundayo.^[9] The plan’s own account runs back through two decisions. In October 2023 the board stopped new users from January 1, 2024, while keeping current users on the drugs.^[10] In January 2024 it voted to end weight-loss coverage entirely from April 1, 2024.^[11]

The formulary does list other routes. These are what it shows.^[9]

Two points need care. The plan’s wellness page says FDA-approved weight management drugs and bariatric surgery are covered benefits, which reads differently from the GLP-1 exclusion; it sends members to the booklet and drug list for restrictions, and the drug list above is the controlling detail.^[16] The same page says in-network nutrition counseling and behavioral intervention are covered in full on the Standard and Plus PPO plans.^[16]

The second point concerns other uses. The board’s exclusion was worded around weight loss, but we found no plan document saying how Wegovy for heart disease or Zepbound for sleep apnea is handled, and neither appears on the formulary.^[9][10] The formulary describes an exception process for medical necessity on non-covered drugs, run by CVS Caremark.^[9] Members with those diagnoses should ask the plan or Caremark in writing. Our guide to Caremark and Zepbound describes how that company’s process usually works.

Why did the State Health Plan drop weight-loss GLP-1s?

Cost and rebates. In 2023 about 24,750 members used the drugs, at $170 million before rebates and roughly $102.2 million after.^[10] Staff told the board that covering them would add $48.50 per subscriber per month to premiums by 2025, for every member.^[10] The treasurer’s office put the net cost at more than $800 per user per month.^[11]

Narrowing coverage looked unworkable at the time. The board’s January 2024 deck listed options such as a higher BMI bar, required lifestyle programs and step therapy, and marked them as losing all rebates, relaying CVS Caremark’s view that terms departing from the label would not earn them.^[10] That is why the choice appeared to be all or nothing, and why Medicaid’s later reach for mandatory programs is worth watching.

Will the State Health Plan restore weight-loss coverage?

Not soon, on the evidence available in November 2026. An October 2025 agreement with CVS Caremark gave the plan the right to negotiate directly with GLP-1 makers, and the treasurer described this as a possible path to restoring coverage.^[12] Carolina Journal reported that Treasurer Brad Briner had sought about $100 million to cover an estimated 14,000 members with a BMI of 38 or higher, and that a plan spokesperson called current prices unaffordable while hoping to restore some coverage later.^[8]

The July 2026 budget law contains no mention of GLP-1s in our text search.^[13] On October 27, 2026 the board approved a $400 million funding adjustment after warning the plan could run out of cash by year-end.^[14] Pharmacy benefits move to a Blue Cross NC consortium on January 1, 2028, which may reopen the question.^[15] If you are paying cash in the meantime, our guide to the lowest GLP-1 prices without insurance covers the current programs, and the Medicaid checker helps if your eligibility changes.